Q4 2024 OrthoPediatrics Corp Earnings Call Transcript

Mar 4, 2025 / 09:30 PM GMT

Release Date Price: €21.8 (-1.80%)

Transcript 10-K8-K

Key Points

Positve

OrthoPediatrics Corp (KIDS) achieved record highs by helping over 138,000 kids in 2024, demonstrating strong impact and growth.
The company reported a 40% increase in total revenue for Q4 2024, reaching $52.7 million, driven by strong performances in trauma, deformity, and scoliosis segments.
OrthoPediatrics Corp (KIDS) is expanding its market share in pediatric specialty bracing with the OPSB franchise, which is generating higher contribution margins than the implant business.
The company anticipates achieving free cash flow positivity by the fourth quarter of 2025, indicating improved financial health.
OrthoPediatrics Corp (KIDS) is experiencing rapid growth in its DF-2 femur fracture brace, leading to increased demand and expansion of manufacturing capabilities.

Negative

International growth was impacted by a decision to slow shipments to South America due to currency fluctuations, affecting revenue.
The company incurred a $3.7 million restructuring charge due to the closure of its Israel office and consolidation of Apifix operations.
Gross profit margin decreased to 68% in Q4 2024 from 71% in the prior year, partly due to reclassification of expenses.
Operating expenses increased by 43% year-over-year, driven by restructuring charges, EU MDR compliance costs, and personnel expansion.
The company faces challenges in scaling manufacturing to meet the high demand for its DF-2 product, indicating potential supply chain constraints.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KIDS.OQ - Orthopediatrics Corp
Q4 2024 OrthoPediatrics Corp Earnings Call
Mar 04, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome to Orthopediatrics Corporation, 4th quarter and full year 2024 earnings conference call. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Trip Taylor from the Gil Martin Group for a few introductory comments. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you for joining today's call. With me from the company are David Bailey, President and

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.